myocardial infarction
QuidelOrtho Recalls Triage Cardiac Panels Due to False Negative Results
The FDA has identified this as a Class I recall, the most serious type of recall, as use of these devices may cause serious injury or death.
QuidelOrtho Gets Canadian Approval for Point-of-Care High-Sensitivity Troponin Test
The immunoassay detects a subunit of the troponin complex released by heart muscle cells after a myocardial infarction.
Ortho Clinical Diagnostics, Hangzhou AllTest Biotech, Others Obtain FDA Clearances in January
Ortho got the green light for a reagent pack used to measure creatine kinase myocardial band on the firm's Vitros 3600 Immunodiagnostic System.
The amplification-free platform uses miRNAs in its ion-exchange platform to return results in less than 30 minutes.
Prevencio, Atlas Genomics to Commercialize Cardiac Blood Tests
The tests use Microsoft's Azure AI-based computing cloud platform for test algorithm processing and scoring and for report generation and delivery.
Mar 16, 2020
May 17, 2019
Jun 27, 2018
FDA Clears Beckman Coulter Troponin Assay
Nov 7, 2017